CRISPR Genome Editing. How, What and Why?
Donate
At the International IVF Initiative, we are committed to providing free access to our educational sessions, webinars, and resources for professionals and individuals passionate about advancing reproductive medicine. We believe that cost should never be a barrier to knowledge and collaboration. By contributing, you’re ensuring that valuable educational resources, expert insights, and collaborative opportunities remain open to all without financial barriers. Together, we can continue to foster a global community dedicated to innovation and excellence in the field of IVF.
Your Donation
Regular price
$10.00
Thank you!
CRISPR Genome Editing. How, What and Why?
DR. HELEN O'NEILL
Dr. Helen O’Neill is a lecturer in Reproductive and Molecular Genetics and Director for the MSc in Reproductive Science and Women’s Health at the Institute for Women’s Health, University College London (UCL). Her research focusses on preimplantation embryo development and the use of genome editing to assess understanding and treatment of disorders of infertility. Dr. O’Neill has an honours degree in Genetics, an MSc in Prenatal Genetics and Fetal Medicine from UCL and did her PhD and postdoctoral research on the genetics of ovarian development in the Department of Stem cell biology and developmental genetics at the National Institute for Medical Research. She lectures both masters and medical students and is active in public engagement involving genome editing. Dr. O’Neill is CEO and Founder of Hertility Health, a precision medicine based approach to reproductive health
